SCHEMBL7993203

SCHEMBL7993203

Oc1cc2ncn(-c3ccccc3)c2cc1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 11/20 1.00
SRC P12931 3/20 1.00
HTT P42858 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7987721 0.98 FGFR1 (0.97) FGFR1SRCHTT
SCHEMBL7989577 0.87 FGFR1 (0.77) FGFR1SRCHTT
SCHEMBL23846263 0.87 FGFR1 (0.76) FGFR1SRCHTT
Hydrochloric Acid SCHEMBL7986454 0.85 FGFR1 (0.74) FGFR1SRCHTT
SCHEMBL7989553 0.84 FGFR1 (1.00) FGFR1SRC
Bromide SCHEMBL7987551 0.83 FGFR1 (0.97) FGFR1SRC
SCHEMBL12730486 0.81 FGFR1 (0.76) FGFR1SRCHTT
SCHEMBL4280861 0.81 FGFR1 (1.00) FGFR1SRCHTT
Hydrochloric Acid SCHEMBL7990178 0.79 FGFR1 (0.73) FGFR1SRCHTT
SCHEMBL19848102 0.79 FGFR1 (0.68) FGFR1SRCHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218388-B1 THERAPY OF PROTEIN TYROSINE KINASE MEDIATED CANCER, ATHEROSCLEROSIS, RESTENOSIS, AND PSORIASIS BY ADMINISTERING BENZIMIDAZOLE DERIVATIVE WARNER-LAMBERT COMPANY 2001-04-17 US disclosed
US-5990146-A TREATING PROTEIN TYROSINE KINASE MEDIATED CANCER; ANTICARCINOGENIC AGENTS; ATHEROSCLEROSIS; RESTENOSIS; PSORIASIS; ANTIPROLIFERATIVE AGENTS WARNER-LAMBERT COMPANY (US) 1999-11-23 US disclosed